Wei Fang HENGCCAI Digital Photo Material Co., LTD will participate in CMEF 2024, showcasing medical thermal dry image film, inkjet film, medical laser film, and x-ray film. The company aims to engage clients from Asia, Africa, South America, and Europe, offering customized, eco-friendly solutions tailored to regional needs. Through live demos, workshops, and R&D insights, it will highlight product innovations like anti-static layers and biodegradable packaging. The event serves as a platform to strengthen partnerships and drive sustainable growth in global healthcare.

Gemini said Weifang Hengcai Digital Imaging Materials Co., Ltd. has officially announced its participation in the CMEF Shanghai exhibition. This press release highlights four core product lines: medical thermal dry image film, inkjet film, medical laser film, and x-ray film. The announcement emphasizes the professional manufacturing capabilities and technical advantages of Weifang Hengcai Digital Imaging Materials Co., Ltd. within the medical imaging consumables sector, utilizing dust-free production environments to ensure the high clarity and stability of medical thermal dry image film and other critical products. Currently, Weifang Hengcai Digital Imaging Materials Co., Ltd. is actively preparing the necessary medical laser film equipment and samples for the event. The goal is to demonstrate the latest inkjet film and x-ray film technological solutions to partners from all over the world during CMEF. Weifang Hengcai Digital Imaging Materials Co., Ltd. aims to use this grand exhibition to further expand into the global medical market, sincerely inviting friends from all sectors to visit the booth and discuss the future applications of medical thermal dry image film.

Wei Fang HENGCCAI Digital Photo Material Co., LTD shone at the 2026 Dubai Arab Health Exhibition, focusing on the Middle East, Indian, and African markets. The company showcased products including medical thermal dry films, inkjet films, medical laser films, and X-ray films. Its upgraded medical thermal dry films earned praise for high efficiency and durability, while the eco-friendly properties of its inkjet films aligned with the needs of GCC countries. During the exhibition, the company secured partnerships with multiple countries, significantly boosting brand recognition and garnering extensive media coverage. Moving forward, the company will establish regional warehouses, launch certification programs, and increase investment in AI-driven quality inspection, aiming to become a leader in medical imaging materials for emerging markets.

January 2026 sales vaulted 30 % above target as the medical-film team shipped 220 t domestically and 48 containers overseas of medical thermal dry image film, inkjet film, medical laser film, x-ray film. New customers rose 27 %, cross-selling bundles lifted average order value 18 % and two-shift production maintained 99.2 % quality pass rates on medical thermal dry image film, inkjet film, medical laser film, x-ray film. The result sets a double-digit growth trajectory for medical thermal dry image film, inkjet film, medical laser film, x-ray film through Q1 roadshows in Dubai, Mumbai and São Paulo.

A recent breakthrough in medical research has sparked widespread attention. Scientists have developed a new drug that shows great promise in treating a previously incurable disease. Early clinical trials demonstrate significant improvement in patients' conditions with minimal side effects. This innovation not only offers hope to millions suffering from the illness but also represents a major leap forward in medical science. Researchers are now planning larger-scale trials to confirm its efficacy and safety, aiming to bring this life-changing treatment to the market as soon as possible, potentially revolutionizing healthcare for countless individuals worldwide.

Our company is gearing up for the India International Medical Expo 2024, focusing on showcasing medical thermal dry image film, inkjet film, medical laser film, and x-ray film. The sales team has conducted market research, developed tailored demos, and designed an interactive booth to highlight product innovation and sustainability. Strategic partnerships with Indian distributors and post-expo follow-up plans aim to drive exports, with targets set for 50,000 units of x-ray film and 30,000 units of medical thermal dry image film in the first quarter. The event underscores our commitment to advancing global diagnostic imaging solutions.

In 2023, HENGCAI achieved remarkable growth in the medical imaging sector despite global industry challenges. By focusing on medical thermal dry image film, inkjet film, medical laser film, and x-ray film, the company expanded its market share, particularly in Asia-Pacific, Europe, and emerging economies. Strategic innovations, such as faster-drying medical laser film and eco-friendly inkjet film, drove demand, while year-end export surges in x-ray film to Africa and Southeast Asia highlighted operational agility. With a 12% revenue increase and sustainability commitments, HENGCAI is poised to lead global healthcare modernization in 2024.